Literature DB >> 10426193

Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-beta1 in vascular smooth muscle.

A Siegert1, E Ritz, S Orth, J Wagner.   

Abstract

Angiotensin II (Ang II) and transforming growth factor (TGF) beta1 play a role in vascular remodeling in hypertension. In this process they may interact on various levels, including that of receptor regulation. This consideration prompted the present study on transcriptional regulation of TGF-beta receptors by Ang II and TGF-beta in vascular smooth muscle cells. Transcriptional expression of the components of the TGF-beta system was demonstrated for TGF-beta and for TGF-beta receptors I, II, and III. As measured by quantitative reverse transcriptase polymerase chain reaction, TGF-beta mRNA increased about 2.4-fold in the presence of 40 pM exogenous TGF-beta. Ang II at 10(-6) M increased TGF-beta mRNA 2.5-fold compared to control cells (P<0.05). Ang II also significantly increased TGF-beta protein concentration in the supernatant of confluent vascular smooth muscle cells. Ang II caused the induction of TGF-beta, but short-term experiments showed TGF-beta receptor II mRNA to be differentially regulated by Ang II and TGF-beta; while TGF-beta caused a 40% decrease in TGF-beta receptor II mRNA after 4 h (P<0.05), Ang II caused an increase by about 70%. In contrast, both TGF-beta and Ang II increased TGF-beta receptor I mRNA to about 260% or 180% of controls (P<0.05). TGF-beta effects were abrogated by coincubation with a TGF-beta neutralizing antibody, and Ang II effects were abrogated by losartan, an AT-1 receptor antagonist. Coincubation of Ang II with the TGF-beta neutralizing antibody did not inhibit the effect of Ang II, indicating that the short-term effects of Ang II on the expression of the TGF-beta receptors are not mediated via TGF-beta. Furthermore, Ang II stimulated DNA synthesis even in the presence of the TGF-beta neutralizing antibody. In conclusion, this study indicates (a) that in vascular smooth muscle TGF-beta receptors are regulated on the RNA level by TGF-beta and Ang II, and (b) that Ang II dependent regulation of TGF-beta receptors is at least partially independent of endogenous TGF-beta. Stimulation of the transcriptional expression of TGF-beta receptors by Ang II may increase sensitivity of vascular smooth muscle cells to TGF-beta.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10426193     DOI: 10.1007/s001090050374

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  9 in total

1.  Fibrosis-related biomarkers and large and small vessel disease: the Cardiovascular Health Study.

Authors:  Isha Agarwal; Alice Arnold; Nicole L Glazer; Eddy Barasch; Luc Djousse; Annette L Fitzpatrick; John S Gottdiener; Joachim H Ix; Richard A Jensen; Jorge R Kizer; Eric B Rimm; David S Siscovick; Russell P Tracy; Tien Y Wong; Kenneth J Mukamal
Journal:  Atherosclerosis       Date:  2015-02-16       Impact factor: 5.162

2.  Chitinase 1 is a biomarker for and therapeutic target in scleroderma-associated interstitial lung disease that augments TGF-β1 signaling.

Authors:  Chun Geun Lee; Erica L Herzog; Farida Ahangari; Yang Zhou; Mridu Gulati; Chang-Min Lee; Xueyan Peng; Carol Feghali-Bostwick; Sergio A Jimenez; John Varga; Jack A Elias
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

3.  Regulation of peroxisome proliferator-activated receptor-γ by angiotensin II via transforming growth factor-β1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells.

Authors:  Venkateswaran Subramanian; Jonathan Golledge; Elizabeth B Heywood; Dennis Bruemmer; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-17       Impact factor: 8.311

4.  Role of TGF-beta1 and MAP kinases in the antiproliferative effect of aspirin in human vascular smooth muscle cells.

Authors:  Santiago Redondo; Emilio Ruiz; Antonio Gordillo-Moscoso; Jorge Navarro-Dorado; Marta Ramajo; Manuel Carnero; Fernando Reguillo; Enrique Rodriguez; Teresa Tejerina
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

5.  Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat.

Authors:  Matthias Schaier; Sabine Liebler; Kerstin Schade; Fujio Shimizu; Hiroshi Kawachi; Hermann-Joseph Grone; Roshantha Chandraratna; Eberhard Ritz; Juergen Wagner
Journal:  J Mol Med (Berl)       Date:  2004-01-08       Impact factor: 4.599

Review 6.  TGFβ signaling and cardiovascular diseases.

Authors:  Evangelia Pardali; Peter Ten Dijke
Journal:  Int J Biol Sci       Date:  2012-01-01       Impact factor: 6.580

7.  Combining use of captopril and losartan attenuates the progress of Streptococcus pneumoniae-induced tympanosclerosis through the suppression of TGF-β1 expression.

Authors:  Wenqing Yan; Jianfeng Li; Renjie Chai; Wentao Guo; Lei Xu; Yuechen Han; Xiaohui Bai; Haibo Wang
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

Review 8.  Genetic and Epigenetic Regulation of Aortic Aneurysms.

Authors:  Ha Won Kim; Brian K Stansfield
Journal:  Biomed Res Int       Date:  2017-01-01       Impact factor: 3.411

9.  Telmisartan improves vascular remodeling through ameliorating prooxidant and profibrotic mechanisms in hypertension via the involvement of transforming growth factor-β1.

Authors:  Peijin Shang; Tianlong Liu; Wenxing Liu; Yuwen Li; Fang Dou; Yikai Zhang; Lijuan Sun; Tiejun Zhang; Zhihui Zhu; Fei Mu; Yi Ding; Aidong Wen
Journal:  Mol Med Rep       Date:  2017-08-04       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.